iSpecimen Inc. 8-K

What Happened
iSpecimen Inc. announced in an 8-K (Item 8.01) that its 2025 Annual Meeting of Stockholders, originally convened on December 31, 2025, was adjourned because a quorum was not present. The meeting was reconvened on January 23, 2026 and February 13, 2026, but each reconvening also lacked a quorum and was adjourned. The company intends to reconvene the Annual Meeting on March 13, 2026 at 9:00 a.m. Eastern Time. The proposals to be voted on remain unchanged and are described in the company’s definitive proxy statement filed with the SEC on November 21, 2025.

Key Details

• Original meeting date: December 31, 2025; reconvened on January 23, 2026 and February 13, 2026.
• Next scheduled reconvening: March 13, 2026 at 9:00 a.m. ET.
• Record date for voting remains November 3, 2025.
• No changes were made to the proposals included in the definitive proxy statement (filed Nov 21, 2025).

Why It Matters
For investors, the repeated adjournments mean shareholder votes on matters in the proxy statement (e.g., director elections or other proposals) remain unresolved and will be delayed until the March 13, 2026 reconvening. The company has stated the adjournments were to allow additional time for stockholders to vote; the record date for determining who may vote is unchanged (Nov 3, 2025). Shareholders who wish to influence the outcome should note the reconvened date and ensure their votes are submitted or updated according to the instructions in the proxy materials.